Infusion Drug Articles & Analysis
19 news found
In today’s evolving pharmaceutical landscape, the search for new drug delivery systems (DDS) is of paramount importance to improving therapeutic outcomes. ...
Good news from vascular medicine: the innovative drug Revacept can protect people with narrowed carotid arteries from both further strokes and dangerous bleeding. ...
Flowonix Medical Inc. of New Jersey, and Colorado-based Cerebral Therapeutics, announced today the first patients implanted with the Prometra II Programmable Infusion System in the Australian Direct Drug Administration for Refractory Epilepsy (ADDRESS) clinical trial at St. ...
Schmid brings extensive operations and business development leadership experience in diabetes and drug delivery. As Vice President of Operations and Business Development at Insulet Corporation, he was instrumental in the development, manufacturing, and commercialization of wearable smart drug delivery pumps such as the Omnipod Diabetes Management System, the ...
Flowonix Medical and Miratech Medical today announced the acquisition of the U.S. distribution rights to Flowonix’s state-of-the-art targeted drug delivery system for the treatment of chronic pain and spasticity by Miratech Medical in a transaction that closed on May 11th. ...
About Ivenix Ivenix, located in North Andover, Mass., is a medical technology company with the vision of eliminating infusion-related errors by transforming infusion delivery. The Ivenix Infusion System includes a large-volume infusion pump, a portfolio of administration sets, and a suite of infusion management ...
SPEARHEAD-1 trial will meet its primary endpoint and data will be used to support BLA filing for afami-cel next year The overall response rate (ORR) per Independent Review was 34% (36% in patients with synovial sarcoma and 25% for patients with MRCLS) and the disease control rate was 85% As of the data cut-off, afami-cel has shown a favorable benefit:risk profile Translational data confirm ...
This product can be used to infuse a variety of pharmaceuticals, such as local anesthetics. Josh Kriesel, President and CEO of BioQ Pharma, commented, “We are delighted to announce that BioQ Pharma has received a CE Mark on a third infusion product in our growing portfolio. ...
About the Prometra II Programmable Infusion System The Prometra Programmable Infusion Pump System is indicated for intrathecal infusion of drug therapy, including: Infumorph® (preservative free morphine sulfate sterile solution), preservative-free sterile 0.9% saline solution (Sodium Chloride Injection, USP), and baclofen ...
Marijn Dekkers commented, “I have gotten to know BioQ’s business well over the last 18 months and am very enthusiastic about the Company’s infusion technology and its many applications. I am looking forward to helping the board grow the business and to continuing to provide strategic counsel as the Company accelerates its commercial ramp.” About BioQ ...
Using BioQ’s patented invenious™ technology, the disposable, electro-mechanical ready-to-use, single use infusion pharmaceutical products, are pre-filled at the point of manufacture with a local anesthetic. ...
Using the Company’s patented invenious™ technology, the Propofusor is a programmable, ready-to-use, single use infusion pharmaceutical product, which is pre-filled at the point of manufacture with 1% propofol, a hypnotic amnestic agent and the world’s most widely used surgical sedation drug. ...
The Italian Biochemical Institute (IBI) “Lrenzini”, Comecer, and Particle Measuring Systems (PMS) recently partnered to leverage and combine the expertise of each entity to design a new drug delivery system and a filling line to safely and effectively manufacture it. ...
"We are confident the combination of the Flowonix Maestro Software and the novel drug delivery mechanism of the Prometra Pump will strengthen our position in the marketplace and set the company up for long-term success in targeted drug delivery. About the Prometra II Programmable Infusion System The Prometra Programmable ...
The Company’s ready-to-use infusion pharmaceutical includes the propofol drug product and delivery system in a single-use unit-dose presentation. ...
About BioQ Pharma BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, ...
” About BioQ Pharma BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, ...
Flowonix Medical, Inc. and Cerebral Therapeutics, Inc. announced today the successful implant of the fifth patient in the ADDRESS (Australian Direct Drug Administration for Refractory Epilepsy) trial. The jointly developed therapy features a micro-infusion device which tightly controls drug delivery to a region of the brain for patients with ...
She still travels to Loyola every three weeks to receive an infusion of the new drug, but her life has been transformed. Loyola University Medical Center is a partner in the Southwest Airlines Medical Transportation Grant Program. ...